[Tuberculosis a threat again. Multiresistance in the Baltic States and in Russia; Nordic countries initiate cooperation to prevent transmission].
The incidence of tuberculosis (TB) has more than doubled in the Baltic States during the last decade and is now 10-15 times higher than in Sweden. It is also a serious problem in Russia. Strains resistant to one or several of the anti-tuberculous drugs are common as is multi-drug resistance (MDR), i.e. strains resistant to the two most effective drugs rifampicin and isoniazid. MDR-TB is very difficult to treat; the mortality rate is high. Initiatives have been taken in the Nordic countries in order to help to control and improve the situation by way of supportive measures.
Rutqvist
A
A
Göteborgs universitet. tb-meeting@medfak.gu.se
Boman
G
G
Ekdahl
K
K
Hoffner
S
S
Julander
I
I
Larsson
L O
LO
Ridell
M
M
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects; D001454:Baltic States / Q000453:epidemiology; D003140:Communicable Disease Control; D021821:Communicable Diseases, Emerging / Q000517:prevention & control / Q000635:transmission; D004196:Disease Outbreaks; D018432:Drug Resistance, Multiple; D006801:Humans; D015994:Incidence; D007391:International Cooperation; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000276:immunology; D017410:Practice Guidelines as Topic; D011859:Radiography; D012426:Russia / Q000453:epidemiology; D012537:Scandinavian and Nordic Countries; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission
D000995:Antitubercular Agents